Alpha-1 Foundation Ireland Chosen as Global Leader

February 7, 2020 Alpha1 Admin Comments Off

Alpha-1 Foundation Ireland has been chosen as a global Alpha-1 leader in a new scheme to help other countries as they develop detection, advocacy, and awareness activities.

Alpha-1 Global announced in February 2020 that three Alpha-1 patient organisations have been selected as Alpha-1 Global Hub Centers. Alpha-1 Foundation Ireland, Fundación Argentina de Alfa-1, and the Alpha-1 Association of Australia have been selected as the inaugural Hub Centers.

The new programme was developed to create global resource centers that could provide mentorship, guidance, and support to less established Alpha-1 patient organisations. For more information on the programme visit http://alpha-1global.org/alpha-1-global-reveals-2020-global-hub-centers/

Info Centre

What is Alpha-1 Antitrypsin?

Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.

What is Alpha-1 Antitrypsin Deficiency?

Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).

How Do I Get Tested?

The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie

Alpha-1 Suite, RCSI Building, Beaumont Hospital, Dublin 9, Ireland
Charity Number CHY22304

Site Developed & Maintained by Ecom-Ireland